The naphthosultam derivative RP 62203 (fananserin) has high affinity for the dopamine D4 receptor

European Journal of Pharmacology

Volumn 314, Issue 1-2, 1996, Pages 229-233

  Heuillet, Edith ^a   Petitet, François ^a   Mignani, Serge ^b   Malleron, Jean Luc ^b   Lavayre, Jacques ^a   Néliat, Gervais ^c   Doble, Adam ^a   Blanchard, Jean Charles ^a  

^a Biology Department   (France)

^b Rhône Poulenc Rorer   (France)

^c CEREP   (France)

Author keywords

5 HT (serotonin); 5 HT(2A) receptor; dopamine; dopamine D4 receptor; fananserin; RP 62203

Indexed keywords

CINANSERIN; CLOZAPINE; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; FANANSERIN; HALOPERIDOL; KETANSERIN; METHYSERGIDE; NEUROLEPTIC AGENT; OLANZAPINE; PRAZOSIN; QUETIAPINE; RADIOLIGAND; RISPERIDONE; RITANSERIN; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SPIPERONE; SULPIRIDE; DRD4 PROTEIN, HUMAN; DRD4 PROTEIN, RAT; NAPHTHALENE DERIVATIVE; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SULFOXIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; BRAIN CORTEX; CHO CELL; CONTROLLED STUDY; CORPUS STRIATUM; DRUG RECEPTOR BINDING; GENE EXPRESSION; HUMAN; MALE; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECOMBINANT DNA TECHNOLOGY; ANIMAL; HAMSTER; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; BINDING, COMPETITIVE; CHO CELLS; CRICETINAE; CYCLIC S-OXIDES; HUMANS; MALE; NAPHTHALENES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 0030600409     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00554-7     Document Type: Article

References (19)

1. Borison, R.L., 1995, Clinical efficacy of serotonin-dopamine antagonists relative to classical neuroleptics, J. Clin. Psychopharmacol. 15, 24S.
2. 2 binding studies, Clin. Neuropharm. 15, Suppl. 1, Pt. B, 581B.
3. 2 receptor antagonist, Br. J. Pharmacol. 105, 27.
4. 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side-effects, Arch. Gen. Psychiatry 49, 538.
5. 3H]RP62203 binding in the rat brain, Eur. J. Pharmacol. 233, 37.
6. Mason, S.B., A.M. Domeny and B. Costall, 1993, Reversal learning impairments induced by amphetamine in the marmoset are attenuated by 5-HT receptor antagonists, Br. J. Pharmacol. 63, 45.
7. Meade, R., K. Huston, L.G. Cornfield, A. Thurkauf, A. Hutchison and J. Tallman, 1995, The in vitro binding profile and functional characteristics of NGD 94-1, a potent and selective D4 antagonist, Soc. Neurosci. Abstr. 1, 617.
8. j, values, J. Pharmacol. Exp. Ther. 251, 238.
9. Mrzljak, L., C. Bergson, M. Pappy, R. Huff, R. Levenson and P.S. Goldman-Rakic, 1996, Localization of dopamine D4 receptors in GABAergic neurons of the primate brain, Nature 381, 245.
10. Ohmori, J., K. Maeno, K. Hidaka, K. Nakato, S. Tsukamoto, S. Sakamoto and T. Mase, 1995, Design, synthesis and biological evaluation of YM-43611, the first selective dopamine D3 and D4 receptor antagonist, American Chemical Society Meeting, Aug. 20-24, Chicago. Abstract MEDI P134.
11. Poel, T.J., C.F. Lawson, D.M. Dinh, M.E. Lajiness, A.G. Romero, J.R. Palmer, D.B. Carter and M.W. Smith, 1995, Substituted aminopiperidines as selective, potent D4-dopamine receptor antagonists, Soc. Neurosci. Abstr. 1, 618.
12. 4 receptor, 7th Swiss Workshop of Methodology Research, March 17-21, Meiringen,
13. 4 receptors in the action and development of antipsychotic drugs, Drugs 51, 7.
14. 4 Dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs, Psychopharmacology 117, 55.
15. Seeman, P., 1992, Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4, Neuropsychopharmacology 7, 261.
16. Seeman, P. and H.H.M. Van Tol, 1994, Dopamine receptor pharmacology, Trends Pharmacol. Sci. 15, 264.
17. Smith, P.K., R.I. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, M.D. Pronenzano, E.K. Fujimoto, N.M. Goeke, B.G. Olsen and D.C. Klunk, 1985. Measurement of protein with bicinchoninic acid, Anal. Biochem. 150, 76.
18. 4 receptor with high affinity for the antipsychotic clozapine. Nature 350, 610.
19. Van Tol, H.H.M., C.M. Wu, H.C. Guan, K. Ohara, J.R. Bunzow, O. Civelli, J. Kennedy, P. Seeman, H.B. Niznik and V. Jovanovic, 1992, Multiple dopamine D4 receptor variants in the human population, Nature 358, 149.